The resignation of DaVita CFO Denise Fletcher is not expected to affect the syndication of the financing backing the company's $3.05 billion acquisition of Gambro Healthcare. LeAnne Zumwalt, v.p. of investor relations, said "We do not believe the deal timing or execution will be affected by [Fletcher leaving]." J.P. Morgan is leading the facility with syndication set for the first of May.
Zumwalt said Fletcher resigned in a "mutual agreement to part ways." Tom Kelly, executive v.p., is serving as temporary cfo. The resignation comes amid a Federal Trade Commission review into the company's intention to buy Gambro's U.S. clinics.